State Street Corp Myovant Sciences Ltd. Transaction History

State Street Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.0 - $26.99 $0 - $78.5 Million	-2,910,023 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$24.03 - $27.02 $21.5 Million - $24.1 Million	893,665 Added 44.32%	2,910,023 $78.5 Million
Q3 2022 Nov 15, 2022	SELL	$11.6 - $20.44 $2.49 Million - $4.39 Million	-214,996 Reduced 9.64%	2,016,358 $36.2 Million
Q2 2022 Aug 15, 2022	SELL	$7.78 - $14.69 $8.59 Million - $16.2 Million	-1,103,581 Reduced 33.09%	2,231,354 $27.7 Million
Q1 2022 May 16, 2022	BUY	$11.38 - $16.4 $5.29 Million - $7.62 Million	464,627 Added 16.19%	3,334,935 $44.4 Million
Q4 2021 Feb 14, 2022	BUY	$14.31 - $23.87 $8.36 Million - $14 Million	584,449 Added 25.57%	2,870,308 $44.7 Million
Q3 2021 Nov 15, 2021	SELL	$18.94 - $26.99 $169,664 - $241,776	-8,958 Reduced 0.39%	2,285,859 $51.3 Million
Q2 2021 Aug 16, 2021	BUY	$17.07 - $24.56 $36 Million - $51.8 Million	2,109,302 Added 1137.0%	2,294,817 $52.3 Million
Q1 2021 Jul 09, 2021	BUY	$20.46 - $25.18 $1.41 Million - $1.74 Million	69,061 Added 59.3%	185,515 $3.82 Million
Q1 2021 May 17, 2021	BUY	$20.46 - $25.18 $437,844 - $538,852	21,400 Added 22.51%	116,454 $2.4 Million
Q4 2020 Feb 16, 2021	BUY	$13.8 - $27.62 $79,488 - $159,091	5,760 Added 6.45%	95,054 $2.63 Million
Q3 2020 Nov 10, 2020	BUY	$14.05 - $22.6 $86,421 - $139,012	6,151 Added 7.4%	89,294 $1.26 Million
Q2 2020 Aug 14, 2020	SELL	$7.34 - $20.84 $21,520 - $61,102	-2,932 Reduced 3.41%	83,143 $1.71 Million
Q1 2020 May 11, 2020	BUY	$6.55 - $14.76 $563,791 - $1.27 Million	86,075 New	86,075 $650,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.